Tags: Coronavirus | merck | coronvirus | antiviral | drug

Merck Plans Large Trials of Antiviral COVID-19 Drug in September

Merck Plans Large Trials of Antiviral COVID-19 Drug in September
(Kena Betancur/Getty Images)

Friday, 31 July 2020 09:24 AM

Drugmaker Merck & Co said on Friday it plans to start two large pivotal trials in September on the experimental oral antiviral COVID-19 drug it is developing with privately held Ridgeback Biotherapeutics.

Speaking on a conference call with investors, Merck's research chief Roger Perlmutter said the company has secured manufacturing capability to make "many millions of doses" of the drug before year end. The experimental drug is currently in phase 2 trials.

© 2020 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
Companies
Drugmaker Merck & Co said on Friday it plans to start two large pivotal trials in September on the experimental oral antiviral COVID-19 drug it is developing with privately held Ridgeback Biotherapeutics.
merck, coronvirus, antiviral, drug
72
2020-24-31
Friday, 31 July 2020 09:24 AM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved